DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Pyridoxal Phosphate is an investigational drug.
There have been 4 clinical trials for Pyridoxal Phosphate. The most recent clinical trial was a Phase 2 trial, which was initiated on July 1st 2011.
The most common disease conditions in clinical trials are Movement Disorders, Dyskinesias, and Protoporphyria, Erythropoietic. The leading clinical trial sponsors are University of Cologne, University of Utah, and Medicure.
There are two US patents protecting this investigational drug and twenty international patents.
Recent Clinical Trials for Pyridoxal Phosphate
|Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria||Icahn School of Medicine at Mount Sinai||N/A|
|Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||N/A|
|Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria||University of Alabama at Birmingham||N/A|
Top disease conditions for Pyridoxal Phosphate
Top clinical trial sponsors for Pyridoxal Phosphate
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Pyridoxal Phosphate||See Pricing||Bone delivery conjugates and method of using same to target proteins to bone||Alexion Pharmaceuticals, Inc. (New Haven, CT)||See Pricing|
|Pyridoxal Phosphate||See Pricing||Particle detecting device||AZBIL CORPORATION (Chiyoda-ku, JP)||See Pricing|
|Pyridoxal Phosphate||See Pricing||Dietary supplement and methods of use||Inovobiologic Inc. (Calgary, CA)||See Pricing|
|Pyridoxal Phosphate||See Pricing||Method of treatment||HEXIMA LIMITED (Bundoora, AU)||See Pricing|
|Pyridoxal Phosphate||See Pricing||Inhibitors of beta integrin-G protein alpha subunit binding interactions||THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (Urbana, IL)||See Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Pyridoxal Phosphate||Austria||505551||2024-04-21||See Pricing|
|Pyridoxal Phosphate||Australia||2005235635||2024-04-21||See Pricing|
|Pyridoxal Phosphate||Canada||2559228||2024-04-21||See Pricing|
|Pyridoxal Phosphate||Germany||602005027461||2024-04-21||See Pricing|
|Pyridoxal Phosphate||Denmark||1759001||2024-04-21||See Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|